dr. tolaney on the evolution of adjuvant treatment for her2 breast cancer
Published 6 years ago • 88 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
1:25
dr. tolaney on the neoadjuvant therapy for her2-positive breast cancer
-
1:32
dr. tolaney on the evolution of treatment in her2 breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:53
dr. tolaney on navigating adjuvant therapy in early-stage her2 breast cancer
-
1:39
dr. tolaney on novel approaches in treating her2-positive breast cancer
-
3:01
dr sara m. tolaney discusses the role of adjuvant therapy in her2-positive breast cancer
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:39
dr tolaney on standard frontline treatment approaches in her2 breast cancer
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
4:26
dr. sara tolaney on adjuvant t-dm1 vs paclitaxel and trastuzumab for stage i her2 breast cancer
-
2:09
adjuvant therapy data for her2-positive breast cancer
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
1:55
dr. tolaney on abemaciclib plus pembrolizumab for hr , her2- breast cancer
-
8:23
adjuvant therapy for her2-driven breast cancer
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
7:37
adjuvant therapy for her2 breast cancer
-
1:29
dr. ali on the future of adjuvant care for her2 breast cancer
-
5:16
factors influencing adjuvant therapy use for her2 breast cancer
-
2:06
dr. tolaney on deescalating therapy in stage i her2 breast cancer